BioVEI Blog

It has been recently noted that small informal feasibility work performed years ago on prototypes is being misinterpreted as conclusive results.

Many meetings were held at the BioVei booth at MEDICA. We wish to thank everyone who stopped by to meet with us. Also present were top representatives of the BioVei team in China from Harbin Pharmaceutical Group, who manufactures the BioVei tests. Harbin Pharmaceutical Group is the largest pharmaceutical company in China and is excited at becoming also the leading diagnostic company. The BioVei China team assured distributors that all orders will be filled with top quality products.

BioVei will be exhibiting at the upcoming MEDICA 2010 in Dusseldorf Germany from November 17^th – 20^th. The BioVei booth will be in the US Pavilion of Hall 3, booth number 3/D15-7. The BioVei team is proud to be presenting its unique rapid Chlamydia test which is CE marked for both POC and OTC use. Please stop by to visit or contact BioVei for more information or to schedule a meeting time at MEDICA.

BioVei will be attending the upcoming AACC event held this year in Anaheim California. Meetings are being scheduled at the EXPO on Wednesday July 28^th and Thursday July 29^th. If you are interested in meeting with the BioVei team, please contact BioVei to schedule and appointment.

Also, team members will be present at the IAFP show in Anaheim following AACC. During August 1^st – 3^rd you can visit them at booth #626 where the innovative products of Vista Enterprises Incorporated (VEI), www.vistaenterprisesinc.com, and FluoroVei LLC, www.fluorovei.com, will be displayed and demonstrated.

BioVei has started 2010 with the successful completion and awarding of a CE mark for the POC & OTC BioVei Chlamydia tests.  BioVei is proud of this achievement, along with its ISO13485 certification and looks forward to marketing its diagnostic tests to Europe and other regions of the world soon.

BioVei announces with regret, that David Wilson of BioScience Business Resources, located in the UK, is no longer acting as BioVei’s sales representative for Europe.  All sales inquiries should be sent to BioVei directly. David chose to pursue other opportunities, and BioVei wishes him well with his endeavors. 

BioVei will continue with its excellent service and assures that there will be no interruption in the relationship between BioVei and its distributors.

BioVei had a successful end to 2009 with the announcement of receiving its ISO13485 certification.  BioVei is proud to have achieved the ISO 13485 certification which is an internationally recognized standard of quality management systems for medical device manufacturers. 

BioVei will be exhibiting at MEDICA, the world forum for medicine.  The MEDICA event is held in Dusseldorf Germany from November 18th through the 21st.  Visit us at our booth located in Hall 3 in the U.S. Pavilion.  Our booth number is 3/D-29-16.  Please feel free to contact us prior to the event with any questions, or if you would like to schedule a specific meeting appointment time.  We look forward to our appearance at this popular event.

BioVei will be attending the AACC in Chicago July 21^st and 22^nd .  BioVei is meeting with several prominent distributors and other interested companies who are excited about

the new rapid testing device from BioVei.

BioVei is pleased to announce a collaboration with BioScience Business Resources, located in the UK,  to set up BioVei’s distribution network in Europe.  BioVei’s team is working closely with David Wilson, the Managing Director, of BioScience, and is happy with the initial response from various countries in Europe.  For more information, or to contact BioScience, please visit their website, www.biosciencebusinessresources.com.